Home
Conditions
Anemia, Refractory

Clinical trial condition

Anemia, Refractory

Explore clinical trials studying Anemia, Refractory. Study availability and eligibility vary by location and protocol.

188 public trials 35 recruiting studies

Refine in advanced search Browse all conditions

Anemia, Refractory trial results

Completed

Brentuximab Vedotin in Patients With CD30-positive Nonlymphomatous Malignancies

NCT01461538

Conditions: Acute Lymphoid Leukemia, Acute Myeloid Leukemia, Anemia, +19 more
Locations: University of Alabama at Birmingham Birmingham, Alabama, United States

City of Hope Duarte, California, United States

PMK Medical Group Inc., DBA Ventura County Hematology Oncology Specialists Oxnard, California, United States

Rocky Mountain Cancer Centers - Aurora Aurora, Colorado, United States

View all 29 locations

View Trial Details

Completed

Basiliximab #2: In-Vivo Activated T-Cell Depletion to Prevent Graft-Versus_Host Disease (GVHD) After Nonmyeloablative Allotransplantation for the Treatment of Blood Cancer

NCT00975975

Conditions: Acute Lymphocytic Leukemia, Acute Myelogenous Leukemia, Anemia, +47 more
Locations: Indiana University Cancer Center Indianapolis, Indiana, United States

View Trial Details

Completed

Chemotherapy and Monoclonal Antibody Therapy in Treating Patients With Advanced Myeloid Cancer

NCT00014495

Conditions: Anemia, Anemia, Refractory, Anemia, Refractory, with Excess of Blasts, +26 more
Locations: Memorial Sloan - Kettering Cancer Center New York, United States

View Trial Details

Completed

Umbilical Cord Blood (UCB) Transplantation in Pediatric Patients With High Risk Leukemia and Myelodysplasia

NCT02007863

Conditions: Acute Lymphocytic Leukemia, Acute Myelogenous Leukemia, Anemia, +18 more
Locations: Jackson Memorial Hospital Miami, Florida, United States

University of Miami Sylvester Comprehensive Cancer Center Miami, Florida, United States

View Trial Details

Completed

Arsenic Trioxide and Gemtuzumab Ozogamicin in Treating Patients With Advanced Myelodysplastic Syndromes

NCT00274781

Conditions: Anemia, Anemia, Refractory, Anemia, Refractory, with Excess of Blasts, +14 more
Locations: Cleveland Clinic Taussig Cancer Center Cleveland, Ohio, United States

View Trial Details

Completed

Study Evaluating the Tolerance and Biologic Activity of Oral Ciclopirox Olamine in Patients With Relapsed or Refractory Hematologic Malignancy

NCT00990587

Conditions: Acute Lymphocytic Leukemia, Acute Myeloid Leukemia, Anemia, +39 more
Locations: Vancouver General Hospital Vancouver, British Columbia, Canada

Princess Margaret Hospital Toronto, Ontario, Canada

View Trial Details

Completed

S9920 Busulfan Compared With Cyclophosphamide in Patients Undergoing Total-Body Irradiation Plus Peripheral Stem Cell Transplantation for Advanced Myelodysplastic Syndrome or Related Acute Myeloid Leukemia

NCT00005866

Conditions: Anemia, Anemia, Refractory, Anemia, Refractory, with Excess of Blasts, +14 more
Locations: Good Samaritan Medical Center Phoenix, Arizona, United States

Arizona Cancer Center Tucson, Arizona, United States

University of Arkansas for Medical Sciences Little Rock, Arkansas, United States

Alta Bates Comprehensive Cancer Center Berkeley, California, United States

View all 66 locations

View Trial Details

Completed

Allo Non-Myeloablative SCT Utilizing Mis-Matched Family Member Stem Cells Purged Using Campath

NCT00580034

Conditions: Anemia, Anemia, Refractory, Anemia, Refractory, with Excess of Blasts, +16 more
Locations: Duke University Health Systems Durham, North Carolina, United States

View Trial Details

Completed

Efficacy Study of T Cell Depleted Allogeneic Non-myeloablative Stem Cell Transplant

NCT00597714

Conditions: Anemia, Anemia, Refractory, Anemia, Refractory, with Excess of Blasts, +19 more
Locations: Duke University Health System Durham, North Carolina, United States

View Trial Details

Completed

Idarubicin, Cytarabine, and Tipifarnib in Treating Patients With Newly Diagnosed Myelodysplastic Syndromes or Acute Myeloid Leukemia

NCT00096122

Conditions: Adult Acute Basophilic Leukemia, Adult Acute Eosinophilic Leukemia, Adult Acute Megakaryoblastic Leukemia (M7), +47 more
Locations: M D Anderson Cancer Center Houston, Texas, United States

View Trial Details

Anemia, Refractory

Anemia, Refractory trial results

Related conditions